» Articles » PMID: 23223431

High Frequency of GATA2 Mutations in Patients with Mild Chronic Neutropenia Evolving to MonoMac Syndrome, Myelodysplasia, and Acute Myeloid Leukemia

Abstract

Unlabelled: Congenital neutropenia is a group of genetic disorders that involve chronic neutropenia and susceptibility to infections. These neutropenias may be isolated or associated with immunologic defects or extra-hematopoietic manifestations. Complications may occur as infectious diseases, but also less frequently as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Recently, the transcription factor GATA2 has been identified as a new predisposing gene for familial AML/MDS. In the present study, we describe the initial identification by exome sequencing of a GATA2 R396Q mutation in a family with a history of chronic mild neutropenia evolving to AML and/or MDS. The subsequent analysis of the French Severe Chronic Neutropenia Registry allowed the identification of 6 additional pedigrees and 10 patients with 6 different and not previously reportedGATA2 mutations (R204X, E224X, R330X, A372T, M388V, and a complete deletion of the GATA2 locus). The frequent evolution to MDS and AML in these patients reveals the importance of screening GATA2 in chronic neutropenia associated with monocytopenia because of the frequent hematopoietic transformation, variable clinical expression at onset, and the need for aggressive therapy in patients with poor clinical outcome.

Key Points: Mutations of key transcription factor in myeloid malignancies.

Citing Articles

GATA2 mutated allele specific expression is associated with a hyporesponsive state of HSC in GATA2 deficiency syndrome.

Largeaud L, Fregona V, Jamrog L, Hamelle C, Dufrechou S, Prade N Blood Cancer J. 2025; 15(1):7.

PMID: 39885120 PMC: 11782539. DOI: 10.1038/s41408-025-01213-z.


Modeling GATA2 deficiency in mice: the R396Q mutation disrupts normal hematopoiesis.

Hall T, Mehmood R, Sa da Bandeira D, Cotton A, Klein J, Pruett-Miller S Leukemia. 2025; 39(3):734-747.

PMID: 39774796 PMC: 11879863. DOI: 10.1038/s41375-024-02508-z.


Inborn Errors of Immunity and Cytokine Storm Syndromes.

Reid W, Romberg N Adv Exp Med Biol. 2024; 1448:185-207.

PMID: 39117816 DOI: 10.1007/978-3-031-59815-9_14.


Malignant progression of preleukemic disorders.

Hall T, Gurbuxani S, Crispino J Blood. 2024; 143(22):2245-2255.

PMID: 38498034 PMC: 11181356. DOI: 10.1182/blood.2023020817.


Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.

Katsumura K, Liu P, Kim J, Mehta C, Bresnick E Proc Natl Acad Sci U S A. 2024; 121(10):e2317147121.

PMID: 38422019 PMC: 10927522. DOI: 10.1073/pnas.2317147121.


References
1.
Hsu A, Sampaio E, Khan J, Calvo K, Lemieux J, Patel S . Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011; 118(10):2653-5. PMC: 3172785. DOI: 10.1182/blood-2011-05-356352. View

2.
Hahn C, Chong C, Carmichael C, Wilkins E, Brautigan P, Li X . Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011; 43(10):1012-7. PMC: 3184204. DOI: 10.1038/ng.913. View

3.
Zhang S, Ma L, Huang Q, Li G, Gu B, Gao X . Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2008; 105(6):2076-81. PMC: 2538883. DOI: 10.1073/pnas.0711824105. View

4.
Minelli A, Maserati E, Giudici G, Tosi S, Olivieri C, Bonvini L . Familial partial monosomy 7 and myelodysplasia: different parental origin of the monosomy 7 suggests action of a mutator gene. Cancer Genet Cytogenet. 2001; 124(2):147-51. DOI: 10.1016/s0165-4608(00)00344-7. View

5.
Owen C, Barnett M, Fitzgibbon J . Familial myelodysplasia and acute myeloid leukaemia--a review. Br J Haematol. 2008; 140(2):123-32. DOI: 10.1111/j.1365-2141.2007.06909.x. View